Recurrence of panic attacks after influenza vaccination: Two case reports

Clinical Psychopharmacology and Neuroscience

Volumn 14, Issue 4, 2016, Pages 396-398

  Kim, Han Joon ^a   Jeon, Sang Won ^a   Yoon, Ho Kyoung ^a  

^a Korea University   (South Korea)

Author keywords

Adverse effects; Human influenza; Influenza vaccines; Panic attack

Indexed keywords

ALPRAZOLAM; ESCITALOPRAM; LORAZEPAM; MIRTAZAPINE; PAROXETINE; TIANEPTINE; TRAZODONE;

ADULT; ANTICIPATORY ANXIETY; ARTICLE; CASE REPORT; CHEST TIGHTNESS; DISEASE EXACERBATION; DIZZINESS; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; HAND; HEART PALPITATION; HUMAN; INFLUENZA VACCINATION; MALE; MIDDLE AGED; PANIC; PATIENT WORRY; RECURRENT DISEASE; SENSATION; SKIN TINGLING; SWEATING; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT DURATION;

EID: 84992488268     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2016.14.4.396     Document Type: Article

References (15)

1. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 2003; 21: 1776-1779.
2. Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995; 346: 591-595.
3. Cheong HJ. Safety of influenza vaccine. J Korean Med Assoc 2007; 50: 267-273.
4. Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011; 205: 473.e1-e9.
5. Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol 2007; 137 Suppl 1: S46-S50.
6. Cho H, Kang H. Host immune responses against type a influenza viruses. J Bacteriol Virol 2014; 44: 133-139.
7. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: A neurodegeneration hypothesis of depression. Med Hypotheses 2003; 61: 519-525.
8. Myint AM, Kim YK. Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48: 304-313.
9. Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009; 26: 447-455.
10. Andreoli A, Keller SE, Rabaeus M, Zaugg L, Garrone G, Taban C. Immunity, major depression, and panic disorder comorbidity. Biol Psychiatry 1992; 31: 896-908.
11. Keller SE, Weiss JM, Schleifer SJ, Miller NE, Stein M. Suppression of immunity by stress: Effect of a graded series of stressors on lymphocyte stimulation in the rat. Science 1981; 213: 1397-1400.
12. Akiyoshi J, Isogawa K, Tsutsumi T, Kasturagi S, Kohno K, Furuta M, et al. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia. Biol Psychiatry 1997; 42: 151-154.
13. Schleifer SJ, Keller SE, Bartlett JA. Panic disorder and immunity: Few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain Behav Immun 2002; 16: 698-705.
14. Park JE, Kim SW, Park Q, Jeong DU, Yu BH. Lymphocyte subsets and mood states in panic disorder patients. J Korean Med Sci 2005; 20: 215-219.
15. Kim YR, Park Q, Yu BH. Changes in lymphocyte subsets after short-Term pharmacotherapy in patients with panic disorder. Psychiatry Res 2004; 128: 183-190.